INDICATORS OF THE LEVEL OF SUBJECTIVE CONTROL IN MALE PATIENTS WITH MILD OR SEVERE PSORIASIS WITHOUT TAKING INTO ACCOUNT SOMATOTYPE AND WITH TAKING INTO ACCOUNT SOMATOTYPE

Authors:

Abstract:

In men with mild or severe psoriasis, compared with healthy subjects without division into somatotypes, the level of subjective control showed a significant decrease in the value of interpersonal relationships and the ability to influence their own health. Significantly lower levels of general internality in patients with severe psoriasis were found in the distribution by body type in men of mesomorphic somatotype as well as the indicator of the level of subjective control in the field of failures, educational and interpersonal relationships in patients with mild and severe disease compared with the control group of a similar somatotype.

Keywords:

psoriasis severity men level of subjective control body type

References:

1. Bazhin EF, Golyinkina EA, Etkind AM. Metod issledovaniya urovnya subyektivnogo kontrolya. Psihologicheskiy zhurnal. 1984;5(3):152–62. [in Russian]
2. Bozina MA. Osobennosti mezhlichnostnogo obshcheniya u lyudey s raznyim urovnem refleksii i subyektivnogo kontrolya. Molodoy uchenyiy. 2020;3(293):286–9. [in Russian]
3. Chandra A, Ray A, Senapati S, Chatterjee R. Genetic and epigenetic basis of psoriasis pathogenesis. Molecular immunology. 2015; 64(2):313–23. doi: 10.1016/j.molimm.2014.12.014
4. Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GB, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. Journal of Investigative Dermatology. 2015; 135(4):984–91. doi: 10.1038/jid.2014.530
5. Gieler U, Gieler T, Peters EMJ, Linder D. Skin and Psychosomatics–Psychodermatology today. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2020;18(11):1280–98. doi: 10.1111/ddg.14328
6. Kwon CW, Fried RG, Nousari Y, Ritchlin C, Tausk F. Psoriasis: Psychosomatic, somatopsychic, or both?. Clinics in dermatology. 2018; 36(6):698–703. doi: 10.1016/j.clindermatol.2018.08.009
7. Lahfa M. Definition and psychopathology of chronic hand dermatitis. Ann Dermatol Venereol. 2014; 141(1):S106–10. doi: 10.1016/S0151-9638(14)70147-4
8. Lakshmy S, Balasundaram S, Sarkar S, Audhya M, Subramaniam E. A cross-sectional study of prevalence and implications of depression and anxiety in psoriasis. Indian journal of psychological medicine. 2015; 37(4):434–40. doi: 10.1038/jid.2013.508
9. Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U, et al. Gender and age significantly determine patient needs and treatment goals in psoriasis–a lesson for practice. Journal of the EuropeanAcademy of Dermatology and Venereology. 2019; 33(4):700–8. doi: 10.1111/jdv.15324
10. Miyagaki T, Sugaya M. Recent advances in atopic dermatitis and psoriasis: genetic background, barrier function, and therapeutic targets. Journal of dermatological science. 2015; 78(2):89–94. doi: 10.1016/j.jdermsci.2015.02.010
11. Schonmann Y, Ashcroft DM, Iskandar IY, Parisi R, Sde‐Or S, Comaneshter D, et al. Incidence and prevalence of psoriasis in Israel between 2011 and 2017. Journal of the EuropeanAcademy of Dermatology and Venereology. 2019; 33(11):2075–81. doi: 10.1111/jdv.15762
12. Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017; 176:650–8. doi: 10.1111/bjd.15021
13. Takeshita J, Gelfand JM, Li P, Pinto L, Yu X, Rao P, et al. Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use. Journal of Investigative Dermatology. 2015; 135(12):2955–63. doi: 10.1038/jid.2015.296
14. Yemchenko YaA, Ishhejkin KYe, Kaidashev IP. Dynamics of clinical and laboratory indicators in the treatment of patients with psoriasis and concomitant alimentary obesity. World of Medicine and Biology. 2021; 1(75): 55–8. doi: 10.26724/2079-8334-2021-1-75-55-58
15. Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA dermatology. 2013;149(10):1173–9. doi: 10.1001/jamadermatol.2013.5015

Publication:

«World of Medicine and Biology» Vol. 18 No. 79 (2022) , с. 126-130
УДК 616.517-055.1:159.923

DOI:

https://doi.org/10.26724/2079-8334-2022-1-79-126-130